|
|
 Previous Article | Table of Contents | Next Article 
Engraftment of Cultured Human Hematopoietic Cells in Sheep
Yoshifumi Shimizu,
Makio Ogawa,
Masao Kobayashi,
Graca Almeida-Porada, and
Esmail D. Zanjani
From the Department of Medicine, Medical University of South
Carolina, Charleston, SC; and Department of Veterans
Affairs Medical Centers, Charleston, SC and Reno, NV.
In an effort to expand human hematopoietic progenitors and stem
cells in vitro, we cultured human
CD34+c-kitlow bone marrow cells in suspension
in the presence of KIT ligand, FLK2/FLT3 ligand, interleukin-6 (IL-6),
and erythropoietin with or without IL-3 and tested their engrafting
capabilities by injecting them into sheep fetuses. As markers for
engraftment, we analyzed CD45+ cells and karyotypes of
the colonies grown in methylcellulose culture. In three separate
experiments, day-60 engraftment in the bone marrow was seen with both
fresh cells and cells cultured in the presence or absence of IL-3. When
fetuses were allowed to be born and analyzed for CD45+
cells, no long-term engraftment was seen with cultured cells. We then
pooled the CD45+ cells of the fetal samples and
transplanted them into secondary recipient fetuses. Day-60 engraftment
in the secondary recipients was again noted when transplantation in the
primary recipients was initiated with fresh cells. There were 3 cases
in which cultured cells showed signs of engraftment in the secondary
recipients, but the remaining 24 cases showed no signs of engraftment.
These data documented that suspension culture for 2 weeks of enriched adult human bone marrow cells can maintain short-term (2 months) engrafting cells, but may not maintain longer term engrafting cells.
This sheep/human xenograft model may serve as an excellent method for
the evaluation of the engraftment potential of in vitro-expanded cells.
Blood, Vol. 91 No. 10 (May 15), 1998:
pp. 3688-3692
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. S. T.-D. Ravin, D. R. Kennedy, N. Naumann, J. S. Kennedy, U. Choi, B. J. Hartnett, G. F. Linton, N. L. Whiting-Theobald, P. F. Moore, W. Vernau, et al.
Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy
Blood,
April 15, 2006;
107(8):
3091 - 3097.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Almeida-Porada, C. D. Porada, J. Chamberlain, A. Torabi, and E. D. Zanjani
Formation of human hepatocytes by human hematopoietic stem cells in sheep
Blood,
October 15, 2004;
104(8):
2582 - 2590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Noia, L. Pierelli, G. Bonanno, G. Monego, A. Perillo, S. Rutella, A. F. Cavaliere, M. De Santis, M. S. Ligato, G. Fotunato, et al.
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity
Stem Cells,
November 1, 2003;
21(6):
638 - 646.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Tsai, H. L. Malech, M. R. Kirby, A. P. Hsu, N. E. Seidel, C. D. Porada, E. D. Zanjani, D. M. Bodine, and J. M. Puck
Retroviral transduction of IL2RG into CD34+ cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras
Blood,
June 17, 2002;
100(1):
72 - 79.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ro{beta}manith, B. Schroder, G. Bug, P. Muller, T. Klenner, R. Knaus, D. Hoelzer, and O.G. Ottmann
Interleukin 3 Improves the Ex Vivo Expansion of Primitive Human Cord Blood Progenitor Cells and Maintains the Engraftment Potential of SCID Repopulating Cells
Stem Cells,
July 1, 2001;
19(4):
313 - 320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. D. Lewis, G. Almeida-Porada, J. Du, I. R. Lemischka, K. A. Moore, E. D. Zanjani, and C. M. Verfaillie
Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system
Blood,
June 1, 2001;
97(11):
3441 - 3449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kimura, J. Wang, H. Minamiguchi, H. Fujiki, S. Harada, K. Okuda, H. Kaneko, S. Yokota, K. Yasukawa, T. Abe, et al.
Signal through gp130 Activated by Soluble Interleukin (IL)-6 Receptor (R) and IL-6 or IL-6R/IL-6 Fusion Protein Enhances Ex Vivo Expansion of Human Peripheral Blood-Derived Hematopoietic Progenitors
Stem Cells,
November 1, 2000;
18(6):
444 - 452.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. D. Bunting, S. Zhou, T. Lu, and B. P. Sorrentino
Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo
Blood,
August 1, 2000;
96(3):
902 - 909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Kollet, R. Aviram, J. Chebath, H. ben-Hur, A. Nagler, L. Shultz, M. Revel, and T. Lapidot
The Soluble Interleukin-6 (IL-6) Receptor/IL-6 Fusion Protein Enhances In Vitro Maintenance and Proliferation of Human CD34+CD38-/low Cells Capable of Repopulating Severe Combined Immunodeficiency Mice
Blood,
August 1, 1999;
94(3):
923 - 931.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Deisseroth
Clinical Trials Involving Multidrug Resistance Transcription Units in Retroviral Vectors
Clin. Cancer Res.,
July 1, 1999;
5(7):
1607 - 1609.
[Full Text]
[PDF]
|
|
|
|
|
